跳至主要内容
临床试验/ITMCTR2200005967
ITMCTR2200005967尚未招募未知

Clinical study of Zisheng Wan Recipe in the treatment of targeted drug-related diarrhea

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • (1) Those diagnosed with non-small cell lung cancer by histopathology;
  • (2) Currently receiving targeted drug therapy and meeting the diagnostic criteria for mild or moderate diarrhea;
  • (3) In line with the results of TCM syndrome differentiation of spleen and stomach weakness
  • (4) Karnofsky score = 70 points, ZPS score = 2 points;
  • (5) The age is 18-80 years old (inclusive), and the gender is not limited;
  • (6) Estimated survival time > 3 months;
  • (7) No intellectual or mental disorder, normal language expression ability, ability to judge their own general condition, and cooperative evaluation of diarrhea and quality of life;
  • (8) Those who understand and agree to participate in this study and sign the informed consent form.
  • Another 10 patients with non-targeted therapy for non-small cell lung cancer recruited were required to have no targeted therapy and were more than 2 weeks away from the oncology western medicine system treatment, such as chemotherapy, targeted therapy, radiotherapy, and immunotherapy.

排除标准

  • 1. Those who do not meet the inclusion criteria;
  • 2. Those with functional impairment of important organs;
  • 3. Caused by other causes (such as irritable bowel syndrome, allergic enteritis, infectious diarrhea, infectious diarrhea, ulcerative colitis, malabsorption, parasitic infection, poisoning, bacillary dysentery, cholera, typhoid and paratyphoid fever) , diarrhea caused by radiation enteritis, hyperthyroidism, hypothyroidism, food and drug allergies, radiation enteritis, metabolic diseases, etc.); patients with persistent or chronic diarrhea before using targeted drugs;
  • 4. Allergic constitution, allergic to montmorillonite powder and traditional Chinese medicine;
  • 5. Those who cannot take the drugs involved in this clinical study;
  • 6. Those who have participated in clinical trials of other drugs within the past 3 months;
  • 7. Drugs that may affect gastrointestinal function and thus affect the judgment of efficacy have been used within one week (such as H-receptor antagonists, proton pump inhibitors, macrolide antibiotics, misoprostol, acarbose, lactose Fructose oral solution, biguanides, etc.);
  • 8. Those with other progressive serious diseases (such as diabetes, hypertension, hyperthyroidism with serious complications);
  • 9. Patients with serious complications (such as hypovolemic shock, gastrointestinal perforation, severe bleeding, nephrotic syndrome, etc.);
  • 10. Women who are pregnant or breastfeeding, or women who have the desire to become pregnant in the near future;
  • 11. Those with severe mental disorders or communication disorders;
  • 12. Those who cannot follow up on schedule or those with poor compliance.

研究者

发起方
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验